David Hollander
Net worth: - $ as of 31/05/2026
Net worth: - $ as of 31/05/2026
David A. Hollander is an Independent Director at Kiora Pharmaceuticals, Inc. since 2021 and a Director at Arnold & Mabel Beckman Foundation.
Former roles include VP & Head-Eye Care for Global Medical Affairs at Allergan, Inc., Chief Research & Development Officer at Aerie Pharmaceuticals, Inc. from 2019 to 2022, Chief Medical Officer & Senior Vice President at Ora, Inc., and Chief Medical Officer at Revance Therapeutics, Inc. from 2022 to 2025.
Education includes undergraduate studies at Stanford University, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the University of Pennsylvania Medical Center.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Director/Board Member | 13/12/2021 |
Arnold & Mabel Beckman Foundation
Arnold & Mabel Beckman Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 04/02/2025 |
| AERIE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 28/02/2022 |
| ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | - |
Ora, Inc.
Ora, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products and provides clinical research services | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arnold & Mabel Beckman Foundation
Arnold & Mabel Beckman Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Ora, Inc.
Ora, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products and provides clinical research services | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions